Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases

被引:4
|
作者
Chen, Luxia [1 ]
Lei, Xuan [1 ]
Mahnke, Karsten [1 ]
机构
[1] Univ Hosp Heidelberg, Dept Dermatol, Neuenheimer Feld 440, D-69120 Heidelberg, Germany
关键词
adenosine receptors; inflammation; psoriasis; hyperplasia; immunosuppression; PLAQUE-TYPE PSORIASIS; ORAL CF101 DATA; MOUSE MODEL; KERATINOCYTE PROLIFERATION; INTERNATIONAL UNION; TOPICAL APPLICATION; A(2B) RECEPTORS; IL-6; PRODUCTION; GLUCOSE-UPTAKE; UP-REGULATION;
D O I
10.3390/ijms25115810
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inflammatory skin diseases highlight inflammation as a central driver of skin pathologies, involving a multiplicity of mediators and cell types, including immune and non-immune cells. Adenosine, a ubiquitous endogenous immune modulator, generated from adenosine triphosphate (ATP), acts via four G protein-coupled receptors (A1, A2A, A2B, and A3). Given the widespread expression of those receptors and their regulatory effects on multiple immune signaling pathways, targeting adenosine receptors emerges as a compelling strategy for anti-inflammatory intervention. Animal models of psoriasis, contact hypersensitivity (CHS), and other dermatitis have elucidated the involvement of adenosine receptors in the pathogenesis of these conditions. Targeting adenosine receptors is effective in attenuating inflammation and remodeling the epidermal structure, potentially showing synergistic effects with fewer adverse effects when combined with conventional therapies. What is noteworthy are the promising outcomes observed with A2A agonists in animal models and ongoing clinical trials investigating A3 agonists, underscoring a potential therapeutic approach for the management of inflammatory skin disorders.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] The oxysterome and its receptors as pharmacological targets in inflammatory diseases
    Guillemot-Legris, Owein
    Muccioli, Giulio G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (21) : 4917 - 4940
  • [22] Adenosine receptors in inflammatory disorders
    Varani, Katia
    Borea, Pier Andrea
    PURINERGIC SIGNALLING, 2012, 8 (01) : 126 - 127
  • [23] Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis
    Nedoszytko, Boguslaw
    Sokolowska-Wojdylo, Malgorzata
    Ruckemann-Dziurdzinska, Katarzyna
    Roszkiewicz, Jadwiga
    Nowicki, Roman J.
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2014, 31 (02): : 84 - 91
  • [24] The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases
    Weiss, E
    Mamelak, AJ
    La Morgia, S
    Wang, B
    Feliciani, C
    Tulli, A
    Sauder, DN
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (05) : 657 - 675
  • [25] THE TOLL-LIKE RECEPTORS ROLE IN INFLAMMATORY DISEASES OF THE BRONCHOPULMONARY SYSTEM PATHOGENESIS
    Korovkina, E. S.
    Kazharova, S., V
    INFEKTSIYA I IMMUNITET, 2016, 6 (02): : 109 - 116
  • [26] Adenosine in inflammatory joint diseases
    E. S. L. Chan
    P. Fernandez
    B. N. Cronstein
    Purinergic Signalling, 2007, 3 : 145 - 152
  • [27] Role of the gut microbiome in the pathogenesis and treatment of inflammatory bowel diseases
    Kempski, Jan
    Huber, Samuel
    INNERE MEDIZIN, 2022, 63 (10): : 1022 - 1027
  • [28] Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases
    Levine, Arie
    Boneh, Rotem Sigall
    Wine, Eytan
    GUT, 2018, 67 (09) : 1726 - +
  • [29] Adenosine in inflammatory joint diseases
    Chan, E. S. L.
    Fernandez, P.
    Cronstein, B. N.
    PURINERGIC SIGNALLING, 2007, 3 (1-2) : 145 - 152
  • [30] Genetic factors in pathogenesis, course and treatment of inflammatory bowel diseases
    Zatorski, Hubert
    Salaga, Maciej
    Zielinska, Marta
    Fichna, Jakub
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2015, 69 : 335 - 344